The global peptide drug conjugates industry is expected to be worth US$ 861.12 million in 2023 and US$ 5,331.83 million by 2033. Over the forecast period of 2023 to 2033, the predicted growth rate is about 20%. The growth of the market is attributed to the global upsurge in cancer cases and related mortality, strong clinical trial …
Tag Archives: Peptide Drug Conjugates Industry
Peptide Drug Conjugates Industry is poised to evolve into a US$ 5,331.83 Million by 2033, promising a novel approach to disease management | FMI
The Peptide Drug Conjugates Industry refers to the pharmaceutical sector focused on the development and commercialization of therapeutic compounds that combine peptides with other molecules, such as small molecules or antibodies. These conjugates offer targeted delivery and enhanced therapeutic efficacy for a wide range of diseases, including cancer, metabolic disorders, and infectious diseases. The PDC …